Vision Point Advisory Group, LLC United Therapeutics Corp Transaction History
Vision Point Advisory Group, LLC
- $473 Million
- Q3 2025
A detailed history of Vision Point Advisory Group, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Vision Point Advisory Group, LLC holds 1,149 shares of UTHR stock, worth $485,486. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,149
Previous 1,307
12.09%
Holding current value
$485,486
Previous $375,000
28.27%
% of portfolio
0.1%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding UTHR
# of Institutions
750Shares Held
43.4MCall Options Held
340KPut Options Held
318K-
Black Rock Inc. New York, NY5.47MShares$2.31 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.45MShares$1.88 Billion0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.37MShares$1 Billion12.42% of portfolio
-
State Street Corp Boston, MA2.17MShares$916 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.12MShares$895 Million0.86% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $19.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...